ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $195,000 | +68.1% | 32,260 | 0.0% | 0.00% | – |
| Q3 2019 | $116,000 | +70.6% | 32,260 | +27.6% | 0.00% | – |
| Q2 2019 | $68,000 | -9.3% | 25,275 | 0.0% | 0.00% | – |
| Q1 2019 | $75,000 | +87.5% | 25,275 | 0.0% | 0.00% | – |
| Q4 2018 | $40,000 | -49.4% | 25,275 | +18.3% | 0.00% | – |
| Q3 2018 | $79,000 | +49.1% | 21,357 | +13.0% | 0.00% | – |
| Q2 2018 | $53,000 | -40.4% | 18,903 | -21.2% | 0.00% | – |
| Q1 2018 | $89,000 | -33.6% | 23,987 | -48.2% | 0.00% | – |
| Q4 2017 | $134,000 | -35.3% | 46,345 | 0.0% | 0.00% | – |
| Q3 2017 | $207,000 | +5.6% | 46,345 | +8.0% | 0.00% | – |
| Q2 2017 | $196,000 | +64.7% | 42,900 | +53.8% | 0.00% | – |
| Q1 2017 | $119,000 | +1.7% | 27,900 | -1.5% | 0.00% | – |
| Q4 2016 | $117,000 | -14.0% | 28,327 | +65.1% | 0.00% | – |
| Q3 2016 | $136,000 | -3.5% | 17,161 | -4.7% | 0.00% | – |
| Q2 2016 | $141,000 | +0.7% | 18,010 | 0.0% | 0.00% | – |
| Q1 2016 | $140,000 | -15.7% | 18,010 | +15.7% | 0.00% | – |
| Q4 2015 | $166,000 | +61.2% | 15,567 | 0.0% | 0.00% | – |
| Q3 2015 | $103,000 | -16.9% | 15,567 | +7.4% | 0.00% | – |
| Q2 2015 | $124,000 | -15.6% | 14,501 | 0.0% | 0.00% | – |
| Q1 2015 | $147,000 | -18.8% | 14,501 | 0.0% | 0.00% | – |
| Q4 2014 | $181,000 | +16.0% | 14,501 | -3.1% | 0.00% | – |
| Q3 2014 | $156,000 | – | 14,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |